⭐ Market Shake-Up: 7 Stocks Earn Coveted 5-Star Rating as Salesforce & S&P Turn Deeply Undervalued

  • Weekly Giveaway for our active users. N50,000 per Week. Do you want to contribute to this community? We are looking for contribution? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing Nigerian forum!

Olori Uwem

Well-Known Member
Mar 18, 2024
1,810
96
48
⭐ Market Shake-Up: 7 Stocks Earn Coveted 5-Star Rating as Salesforce & S&P Turn Deeply Undervalued

Fresh valuation updates from Morningstar show a major shift in opportunity across US equities, with seven stocks newly upgraded to 5-star status — signaling significant undervaluation.

Among the biggest names making the list?
Salesforce
S&P Global

Here’s a detailed breakdown of what’s happening

Market Context: Why Ratings Are Changing
• The Morningstar US Market Index fell 1.29% for the week ended Feb. 13.
• The broader US market is now trading at an 8% discount to fair value.
• Of 828 US-listed stocks under coverage:
• 35% are undervalued
• 39% are fairly valued
• 26% are overvalued
• 7 stocks moved from ⭐⭐⭐⭐ to ⭐⭐⭐⭐⭐ (5-star territory).

A 5-star rating indicates a stock is trading at a material discount to its intrinsic value, based on price, fair value estimate, and uncertainty.

The Largest New 5-Star Stocks

Here are the five highest market-cap names newly rated 5 stars:
• Salesforce (CRM)
• S&P Global (SPGI)
• IQVIA (IQV)
• Dassault Systemes (DASTY)
• Molina Healthcare (MOH)

Let’s break them down individually.

1️⃣ Salesforce (CRM)
⭐ Morningstar Rating: 5 Stars
• Fair Value Estimate: $325
• Trading at: 42% discount
⚠️ Uncertainty: High
• Economic Moat: Wide

Salesforce has fallen:
• 21% in the past 3 months
• 42% in the past year

The sharp sell-off pushed the stock into deep undervaluation territory, creating a significant gap between price and intrinsic value.

2️⃣ S&P Global (SPGI)
⭐ Morningstar Rating: 5 Stars
• Fair Value Estimate: $570
• Trading at: 28% discount
⚠️ Uncertainty: Low
• Economic Moat: Wide

The financial data giant:
• Dropped 6.77% this week
• Down nearly 24% over the past year

With low uncertainty and a wide moat, analysts see this pullback as compelling.

3️⃣ IQVIA (IQV)
⭐ Morningstar Rating: 5 Stars
• Fair Value Estimate: $268
• Trading at: 38% discount
⚠️ Uncertainty: Medium
• Economic Moat: Narrow

The healthcare analytics firm:
• Fell nearly 11% last week
• Down 25% in 3 months

Recent weakness pushed it firmly into undervalued territory.

4️⃣ Dassault Systemes (DASTY)
⭐ Morningstar Rating: 5 Stars
• New Fair Value Estimate: $31.70 (cut from $37.70)
• Trading at: 34% discount
⚠️ Uncertainty: Medium
• Economic Moat: Wide

Shares plunged:
• 20% last week
• Nearly 50% over the past year

Despite a fair value revision lower, the market selloff appears overdone relative to intrinsic value.

5️⃣ Molina Healthcare (MOH)
⭐ Morningstar Rating: 5 Stars
• Fair Value Estimate: $262
• Trading at: 48% discount
⚠️ Uncertainty: Very High
• Economic Moat: Narrow

The healthcare plans provider:
• Down nearly 50% over the past year
• Slight rebound last week (+2.76%)

This is the deepest discount among the group — but it carries the highest uncertainty.

What a 5-Star Rating Means

Morningstar’s rating is based on:

1️⃣ Current stock price
2️⃣ Fair value estimate (intrinsic worth)
3️⃣ Uncertainty rating
⭐⭐⭐⭐⭐ = Significantly undervalued
⭐⭐⭐ = Fairly valued
⭐ = Overvalued

No stock jumped directly from 3 stars to 5 stars this week — these upgrades reflect gradual price declines into attractive zones.

Key Takeaways for Investors
• Market weakness is creating selective opportunities.
• Several wide-moat companies now trade at 30–40% discounts.
• Tech and data firms are dominating the undervalued list.
• Risk levels vary significantly — from low (S&P Global) to very high (Molina).

This week’s upgrades suggest that while the broader market is only moderately undervalued, pockets of deep value are emerging.